| ABSTRACT(CHINESE) | 第1-6页 |
| ABSTRACT(ENGLISH) | 第6-11页 |
| INTRODUCTION | 第11-31页 |
| PART Ⅰ Role of Cellular FKBP52 Protein in Hydroxyurea Treatment-Mediated Increase in Transduction Efficiency of Recombinant Adeno-associated Virus 2 Vectors | 第31-61页 |
| PART Ⅱ Self-ComplementaryAdeno-AssociatedVirusVectors: Packaging Capacity and Purity | 第61-95页 |
| PART Ⅲ Adeno-associated virus serotype 2/5 mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy | 第95-126页 |
| CONCLUSIONS | 第126-127页 |
| ACKNOWLEDGMENTS | 第127-128页 |
| REVIEW Recent developments in recombinant adeno-associated virus-mediated gene therapy for lung diseases | 第128-145页 |
| ABBREVIATIONS | 第145-148页 |
| 论文独创性声明 | 第148页 |
| 论文使用授权声明 | 第148页 |
